Trexquant Investment LP Raises Stock Position in Maximus, Inc. (NYSE:MMS)

Trexquant Investment LP raised its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 19.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 176,003 shares of the health services provider's stock after buying an additional 29,073 shares during the quarter. Trexquant Investment LP owned 0.31% of Maximus worth $13,139,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Headlands Technologies LLC bought a new stake in Maximus during the 4th quarter worth approximately $290,000. Franklin Resources Inc. raised its position in Maximus by 21.8% in the 4th quarter. Franklin Resources Inc. now owns 6,176 shares of the health services provider's stock valued at $461,000 after buying an additional 1,104 shares during the last quarter. Meeder Asset Management Inc. bought a new position in Maximus during the 4th quarter valued at $1,407,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Maximus by 108.5% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 84,309 shares of the health services provider's stock worth $6,294,000 after acquiring an additional 43,864 shares in the last quarter. Finally, Pictet Asset Management Holding SA raised its holdings in shares of Maximus by 8.6% in the fourth quarter. Pictet Asset Management Holding SA now owns 8,563 shares of the health services provider's stock valued at $639,000 after purchasing an additional 676 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Activity

In other Maximus news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Remove Ads

Maximus Price Performance

Shares of MMS stock traded down $0.70 during trading on Thursday, hitting $70.33. The company had a trading volume of 504,184 shares, compared to its average volume of 538,198. The stock's 50-day moving average is $69.31 and its two-hundred day moving average is $77.41. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $3.98 billion, a price-to-earnings ratio of 15.12 and a beta of 0.71. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.71%. Maximus's dividend payout ratio (DPR) is presently 25.81%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a research note on Thursday, January 2nd. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.